Liponex Shareholders Approve ImaSight Transaction
At the annual and special meeting of the Liponex shareholders, the shareholders approved the transaction, the name change from "Liponex Inc." to "ImaSight Corp." and the consolidation of Liponex's common shares on a five (5) for one (1) basis. The company expects to file articles of amendment to give effect to the consolidation and name change, conditional upon, and in connection with, the closing of the transaction with ImaSight.
Completion of the proposed transaction remains subject to the fulfillment or waiver of various conditions precedent as more particularly set forth in the acquisition agreement, including the receipt of all required third party consents and all required regulatory approvals.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.